Valeant Pharmaceutic
VRX
End-of-day quote Toronto Stock Exchange - 10/20
15.33CAD
-1.41%
Prev.15.5500
Open15.6000
High15.6700
Low15.2500
Volume876 878
Last news
Financials
Sales 2017 8 687 M
EBIT 2017 3 267 M
R. net 2017 -498 M
Debt 2017 25 892 M
Rend. 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 3,47x
EV / Sales 2018 3,31x
Capitalization 4 218 M
Company
Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a broad range of pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics.It operates through the following segments: The Bausch +...
Sector :
Pharmaceuticals - NEC
Calendar :
2017-11-07 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance16,922,622,5
Spread/Res.-9,3%-32%-32%
Spread/Supp.6,8%34%34%
Support14,411,511,5